Posts

A bitter pill for ARMUNIA: ARYUNA clears confusion test as General Court holds firm on pharma attention (T‑591/24)

[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision

Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE)

‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee

New decision of the Swedish Patent and Market Court of Appeal addresses interface between new safety regulation for packaging of pharmaceuticals and parallel imports

Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship?

Surveying the scene - passing off & surveys

An Improved Improver? - Part 3

Intellectual Property Challenges in the Bio-Pharmaceutical Field